Gao Ping
Biostatistics, Innovatio Statistics Inc., Bridgewater, New Jersey, USA.
Stat Med. 2025 Feb 10;44(3-4):e10310. doi: 10.1002/sim.10310.
Sample size re-estimation (SSR) is perhaps the most used adaptive procedure in both frequentist and Bayesian adaptive designs for clinical trials. The primary focus of all current frequentist and Bayesian SSR procedures is type I error control. We propose a hybrid frequentist-Bayesian SSR approach that focuses on optimizing operating characteristics (OC), which uses simulations to investigate the associated OC and adjusts accordingly. The hybrid approach incorporates the Bayesian predictive power into the frequentist framework of SSR. Simulations show that the hybrid approach can substantially outperform popular frequentist type error-focused SSR procedure. The hybrid approach can substantially improve the effectiveness of SSR using Bayesian predictive power.
样本量重新估计(SSR)可能是在临床试验的频率主义和贝叶斯自适应设计中最常用的自适应程序。当前所有频率主义和贝叶斯SSR程序的主要重点都是控制I型错误。我们提出了一种混合频率主义-贝叶斯SSR方法,该方法侧重于优化操作特性(OC),它使用模拟来研究相关的OC并相应地进行调整。这种混合方法将贝叶斯预测能力纳入了SSR的频率主义框架。模拟表明,该混合方法可以显著优于流行的以频率主义类型错误为重点的SSR程序。该混合方法可以利用贝叶斯预测能力大幅提高SSR的有效性。